PREVAIL THERAPEUTICS INC's ticker is PRVL and the CUSIP is 74140Y101.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2020 | $6,771,000 | +1077.6% | 293,489 | +420.0% | 0.00% | – |
| Q3 2020 | $575,000 | +19.3% | 56,444 | +74.3% | 0.00% | – |
| Q2 2020 | $482,000 | +91.3% | 32,377 | +56.7% | 0.00% | – |
| Q1 2020 | $252,000 | +2.0% | 20,665 | +32.6% | 0.00% | – |
| Q4 2019 | $247,000 | -50.3% | 15,579 | -58.6% | 0.00% | – |
| Q2 2019 | $497,000 | – | 37,642 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Orbimed Advisors | 13,822,463 | $140,713,000 | 1.77% |
| Omega Fund Management, LLC | 187,538 | $1,909,000 | 0.52% |
| Boxer Capital, LLC | 1,123,105 | $11,433,000 | 0.40% |
| RA Capital Management | 1,915,568 | $19,500,000 | 0.36% |
| DAFNA Capital Management LLC | 75,000 | $764,000 | 0.25% |
| QVT Financial LP | 133,690 | $1,361,000 | 0.17% |
| Woodline Partners LP | 385,480 | $3,924,000 | 0.13% |
| Virtus ETF Advisers LLC | 19,773 | $201,000 | 0.10% |
| WEXFORD CAPITAL LP | 37,963 | $386,000 | 0.10% |
| GSA CAPITAL PARTNERS LLP | 53,018 | $540,000 | 0.09% |